Notably, we found that BRF2 amplification was mutually exclusive to the loss of BRCA1 and BRCA2 in breast tumors, both in the TCGA and METABRIC datasets (Supplementary Figure S1E,F). Here, BRF2 is linked to breast neoplasm.